Marinomed Biotech AG (MARI.VI)
EUR 13.0
(-1.89%)
EUR 13.0
(-1.89%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.01 Million EUR | -35.19% |
| 2022 | 1.56 Million EUR | 52.03% |
| 2021 | 1.02 Million EUR | 10.95% |
| 2020 | 926.1 Thousand EUR | 849.85% |
| 2019 | 97.5 Thousand EUR | -15.74% |
| 2018 | 115.7 Thousand EUR | -34.89% |
| 2017 | 177.72 Thousand EUR | 271.87% |
| 2016 | 47.79 Thousand EUR | 0.0% |
| 2015 | - EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 1.05 Million EUR | 4.44% |
| 2023 Q4 | 1.01 Million EUR | -1.23% |
| 2023 Q2 | 1.44 Million EUR | 11.33% |
| 2023 Q3 | 1.02 Million EUR | -29.08% |
| 2023 Q1 | 1.29 Million EUR | -16.89% |
| 2023 FY | 1.01 Million EUR | -35.19% |
| 2022 FY | 1.56 Million EUR | 52.03% |
| 2022 Q4 | 1.56 Million EUR | -20.29% |
| 2022 Q3 | 1.95 Million EUR | 45.3% |
| 2022 Q2 | 1.34 Million EUR | 15.86% |
| 2022 Q1 | 1.16 Million EUR | 13.29% |
| 2021 FY | 1.02 Million EUR | 10.95% |
| 2021 Q2 | 1.86 Million EUR | 37.87% |
| 2021 Q4 | 1.02 Million EUR | -42.95% |
| 2021 Q3 | 1.8 Million EUR | -3.44% |
| 2021 Q1 | 1.35 Million EUR | 46.07% |
| 2020 Q3 | 588.5 Thousand EUR | 5.79% |
| 2020 Q2 | 556.3 Thousand EUR | 2031.42% |
| 2020 Q1 | 26.1 Thousand EUR | -73.23% |
| 2020 FY | 926.1 Thousand EUR | 849.85% |
| 2020 Q4 | 926.1 Thousand EUR | 57.37% |
| 2019 FY | 97.5 Thousand EUR | -15.74% |
| 2019 Q4 | 97.5 Thousand EUR | -28.64% |
| 2019 Q3 | 136.62 Thousand EUR | 986.64% |
| 2019 Q2 | 12.57 Thousand EUR | 0.0% |
| 2019 Q1 | 12.57 Thousand EUR | -89.13% |
| 2018 Q4 | 115.7 Thousand EUR | 361.01% |
| 2018 FY | 115.7 Thousand EUR | -34.89% |
| 2018 Q3 | 25.09 Thousand EUR | 0.0% |
| 2017 Q4 | 177.72 Thousand EUR | 0.0% |
| 2017 FY | 177.72 Thousand EUR | 271.87% |
| 2016 FY | 47.79 Thousand EUR | 0.0% |
| 2015 FY | - EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|